In partnership with
Here’s what’s happening in the stock market today:
The stock market is showing mixed, cautious moves today as investors gear up for major bank earnings and Wednesday’s September CPI inflation report. 📈🔍 Futures for the S&P 500 and Nasdaq are slightly lower, while Dow futures are edging higher, with the Dow having gained 0.38% on Monday to 51,850.55. Oil remains elevated, and the 10-year Treasury yield is holding near 5.24%, keeping inflation and Fed-policy concerns front and center. 🛢️💰
Major Indices Performance 📊
S&P 500 futures are down about 0.1%.
Dow Jones futures are up roughly 0.05%, after Monday’s 0.38% gain.
Nasdaq futures are down about 0.2%, following Monday’s 0.44% decline.
Market Movers 🚀
Bumble (BMBL) is among the session’s top gainers.
Arlington (ARL) and FIGS are also posting notable gains.
CTNM, FMCC, and IMXI are among the biggest decliners.
Memory chip stocks are under pressure after a sharp selloff on Monday, weighing on the Nasdaq.
Key Events Driving the Market 🗞️
Major bank earnings: JPMorgan, Goldman Sachs, Citigroup, and Wells Fargo report quarterly results today, kicking off the third-quarter earnings season. 📊
September CPI report: Wednesday’s inflation data is the week’s main event, with a hot print potentially pushing the 10-year yield back toward 5.3% and pressuring stocks. 📉🏦
Oil stays elevated: Brent crude remains above $100 a barrel, keeping inflation and geopolitical risks alive. 🌍🛢️
Fed officials speak: Remarks from Christopher Waller, Tom Barkin, and Susan Collins are also on investors’ radar. 🏛️
Investor Sentiment 👀
Overall, investor mood is cautiously optimistic but wary, with traders balancing:
Encouragement from strong bank earnings expectations
Support from continued AI and tech momentum
Underlying concern about high yields, elevated oil, and the potential for a hot CPI print to derail the rally
The market is in a “wait-and-see” mode, with bank earnings and inflation data likely to set the tone for the rest of the week. 🐂⚖️
Capital Is Flooding Into The Physical AI Revolution
AI is stepping out of the digital screen and entering the physical world. Robotics VC deal activity hit all-time highs in early 2026, with investments climbing toward sixteen billion dollars across more than four hundred and fifty deals.
Driven by manufacturing labor shortages, aging workforces, and explosive tech breakthroughs from NVIDIA, Tesla, and a host of specialized component suppliers, automation is accelerating across factories and warehouses globally.
Whether you are looking at AI compute, machine vision sensors, motion control actuators, or humanoid robotics, the infrastructure buildout is happening right now. Download our comprehensive guide to discover the top investable robotics sectors and market drivers.
TRADE OF THE DAY
VST
Stock Info
Name: Vistra Corp.
Symbol: VST
Current Price: $160.66
Trade
Sell to Open: 1 VST Oct 30, 2026 140/135 Put Vertical (Bull Put Spread)
Total Credit Received: $38.00
Credit per Contract: $38.00 (for one contract covering 100 shares)
Direction: Bullish (expects VST to remain above the break-even price)
Probability of Profit (PoP): 88.59% (as provided)
Potential ROI
Max Risk (Loss): $462.00 (as provided)
Max Potential Reward: $38.00
ROI: ($38.00 ÷ $462.00) × 100 ≈ 8.2%
Trade Explained in Simple English:
You’re selling the $140 put and buying the $135 put as protection, with both options expiring on October 30, 2026. You receive $38.00 upfront for entering the trade. If VST closes above your break-even price of $139.62 at expiration, you can earn the full $38.00 maximum profit; if VST falls below $135.00, your maximum loss is capped at $462.00. This is a bullish strategy because it benefits when VST stays above the break-even price, with a stated probability of profit of 88.59%.
Wall Street Highlights:
News Beyond the Numbers
JPMorgan Chase posted third-quarter profit of $15.3 billion, up 6% year over year, but earnings per share missed estimates even as it raised its full-year net interest income outlook.Read more.
Goldman Sachs reported third-quarter revenue of $18.68 billion, well above expectations, with equities-trading revenue of $6.44 billion beating forecasts while fixed-income trading fell short.Read more.
Johnson & Johnson beat third-quarter estimates on strong sales of its autoimmune treatment Tremfya and raised its full-year profit outlook, though Middle East-related disruptions weighed on medical-device sales.Read more.
UnitedHealth topped third-quarter expectations with adjusted earnings of $4.69 per share and revenue of $112.69 billion, then raised its full-year earnings guidance.Read more.
Wells Fargo reported mixed third-quarter results, with earnings per share of $1.87 slightly above estimates but revenue of $21.87 billion falling short of forecasts.Read more.
Disclaimer: The content provided by OptionPicks is for informational and educational purposes only and should not be construed as investment, financial, legal, or tax advice. We are not registered as a broker-dealer, investment adviser, or financial advisor with the SEC, FINRA, or any other regulatory authority. Options trading involves substantial risk and is not suitable for every investor. Past performance is not indicative of future results, and no representation is being made that any subscriber will or is likely to achieve profits or incur losses similar to those mentioned. You should consult with a licensed financial professional before making any investment decisions.
